Paul Guest, PhD has over 25 years of experience in academic and pharmaceutical company environments in designing, carrying out and documenting all aspects of pre-clinical and clinical studies with a focus on psychiatric disorders, metabolic disorders and stem cell therapeutics. He possesses a diverse set of skills in genomic/proteomic areas including immunological, protein-protein interactions, detection technologies, robotics, functional assays and bioinformatic analyses. He has published more than 120 papers in peer-reviewed journals and contributed over 20 chapters to various contributed volumes.

Combines a multi- disciplinary approach to shed light on new insights that point towards involvement of the whole body in the course of psychiatric disorders

The book covers everything from the history of psychiatric research to the current state-of-the art in psychiatric practice and the impact that this is having on emerging biomarker discoveries

Incorporates personalized medicine approaches into these processes to help move psychiatric medicine into the 21stcentury

Includes supplementary material: [...]

Part I.- CHAPTER 1 - Psychiatric disorders as "whole body" diseases.- CHAPTER 2 - Treatment of psychiatric disorders: time for a paradigm change?.- CHAPTER 3 - The importance of biomarkers: the required tools of the trade.- Part II.- CHAPTER 4 - Schizophrenia and the mind-body connection.- CHAPTER 5 - Progress for better treatment of depression.- CHAPTER 6 - The special case of bipolar disorder.- CHAPTER 7 - The worrying case of anxiety and stress-related disorders.- CHAPTER 8 - The autism spectrum conditions and the extreme male brain syndrome.- CHAPTER 9 - Gender and psychiatric disorders.- Part III.- CHAPTER 10 - CHAPTER 10 - Biomarkers and new treatments for Alzheimer's disease.- CHAPTER 11 - Parkinson's disease, biomarkers and beyond.- Part IV.- CHAPTER 12 - The future: towards personalized medicine.